CRUK Convergence Science Centre
@crukconvergence.bsky.social
Bringing together engineering, physical sciences, life sciences and medicine to address key questions in cancer research across @icr.ac.uk and @imperialcollegeldn.bsky.social
convergencesciencecentre.ac.uk
convergencesciencecentre.ac.uk
🤝 Researchers and the community came together for a community partner-led event that sparked new collaborations, fresh ideas and renewed energy for meaningful patient and public #involvement in #CancerResearch.
Read the full article: bit.ly/47QrJML
#PPIE #Cancer
Read the full article: bit.ly/47QrJML
#PPIE #Cancer
November 20, 2025 at 12:00 PM
🤝 Researchers and the community came together for a community partner-led event that sparked new collaborations, fresh ideas and renewed energy for meaningful patient and public #involvement in #CancerResearch.
Read the full article: bit.ly/47QrJML
#PPIE #Cancer
Read the full article: bit.ly/47QrJML
#PPIE #Cancer
🌟 Early Career Clinicians: Apply for our Clinical Research Training Fellowship with @icr.ac.uk and @imperialcollegeldn.bsky.social to build your #research skills and accelerate your #academic career.
👉 bit.ly/3LNTxc1
🗓 Deadline: 11 Jan 2026
#ConvergenceScience #CRF #Cancer #CancerResearch
👉 bit.ly/3LNTxc1
🗓 Deadline: 11 Jan 2026
#ConvergenceScience #CRF #Cancer #CancerResearch
November 17, 2025 at 10:01 AM
🌟 Early Career Clinicians: Apply for our Clinical Research Training Fellowship with @icr.ac.uk and @imperialcollegeldn.bsky.social to build your #research skills and accelerate your #academic career.
👉 bit.ly/3LNTxc1
🗓 Deadline: 11 Jan 2026
#ConvergenceScience #CRF #Cancer #CancerResearch
👉 bit.ly/3LNTxc1
🗓 Deadline: 11 Jan 2026
#ConvergenceScience #CRF #Cancer #CancerResearch
📣Call open for our 2026 Development Fund
Up to £80K for 12 months to support bold, cross-disciplinary #CancerResearch that bridges the life, clinical, #engineering & #PhysicalSciences across @imperialcollegeldn.bsky.social & @icr.ac.uk
➡️ bit.ly/4qVGLID
#FundingOpportunity #ConvergenceScience
Up to £80K for 12 months to support bold, cross-disciplinary #CancerResearch that bridges the life, clinical, #engineering & #PhysicalSciences across @imperialcollegeldn.bsky.social & @icr.ac.uk
➡️ bit.ly/4qVGLID
#FundingOpportunity #ConvergenceScience
November 12, 2025 at 2:00 PM
📣Call open for our 2026 Development Fund
Up to £80K for 12 months to support bold, cross-disciplinary #CancerResearch that bridges the life, clinical, #engineering & #PhysicalSciences across @imperialcollegeldn.bsky.social & @icr.ac.uk
➡️ bit.ly/4qVGLID
#FundingOpportunity #ConvergenceScience
Up to £80K for 12 months to support bold, cross-disciplinary #CancerResearch that bridges the life, clinical, #engineering & #PhysicalSciences across @imperialcollegeldn.bsky.social & @icr.ac.uk
➡️ bit.ly/4qVGLID
#FundingOpportunity #ConvergenceScience
🗣️ Joshua Killilea, iPhD
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
November 6, 2025 at 12:14 PM
🗣️ Joshua Killilea, iPhD
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
Looking for a #PhD in #CancerResearch and #DataScience? 🤔
Applications are now open for our #ConvergenceScience Non-Clinical Data Science PhD programme, in partnership with StatML.
Sign up to 1 of 3 Q+A sessions or check out our website for more information 👉 bit.ly/43bid48
Applications are now open for our #ConvergenceScience Non-Clinical Data Science PhD programme, in partnership with StatML.
Sign up to 1 of 3 Q+A sessions or check out our website for more information 👉 bit.ly/43bid48
November 4, 2025 at 1:36 PM
Looking for a #PhD in #CancerResearch and #DataScience? 🤔
Applications are now open for our #ConvergenceScience Non-Clinical Data Science PhD programme, in partnership with StatML.
Sign up to 1 of 3 Q+A sessions or check out our website for more information 👉 bit.ly/43bid48
Applications are now open for our #ConvergenceScience Non-Clinical Data Science PhD programme, in partnership with StatML.
Sign up to 1 of 3 Q+A sessions or check out our website for more information 👉 bit.ly/43bid48
We’re thrilled to welcome our new CSC Cohort!🚀
Huge thanks to Professors McNeish, Isacke & Behrens for their insights, and to Shahrzad Forouzanfar, Bowen Su & Diana David for introducing our facilities. Here’s to a year of discovery, growth & achievement!💪
#PhD #ConvergenceScience #CancerResearch
Huge thanks to Professors McNeish, Isacke & Behrens for their insights, and to Shahrzad Forouzanfar, Bowen Su & Diana David for introducing our facilities. Here’s to a year of discovery, growth & achievement!💪
#PhD #ConvergenceScience #CancerResearch
October 27, 2025 at 2:47 PM
We’re thrilled to welcome our new CSC Cohort!🚀
Huge thanks to Professors McNeish, Isacke & Behrens for their insights, and to Shahrzad Forouzanfar, Bowen Su & Diana David for introducing our facilities. Here’s to a year of discovery, growth & achievement!💪
#PhD #ConvergenceScience #CancerResearch
Huge thanks to Professors McNeish, Isacke & Behrens for their insights, and to Shahrzad Forouzanfar, Bowen Su & Diana David for introducing our facilities. Here’s to a year of discovery, growth & achievement!💪
#PhD #ConvergenceScience #CancerResearch
🎙️Holger Auner (Lausanne University Hospital)
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
October 23, 2025 at 8:02 AM
🎙️Holger Auner (Lausanne University Hospital)
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
📢 We're #hiring a #Health Economist to be part of our #Cancer Technology Catalyst Team to expedite the journey of promising cancer technologies from concept to clinical impact.
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics
October 21, 2025 at 11:40 AM
📢 We're #hiring a #Health Economist to be part of our #Cancer Technology Catalyst Team to expedite the journey of promising cancer technologies from concept to clinical impact.
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics
Over half of #cancers show MYC deregulation - long seen as “undruggable.” #Research from @imperialcollegeldn.bsky.social & @icr.ac.uk, with #PhD student James Zhang, finds MYC cancers may be vulnerable to NMT inhibitors.
Learn more 👉http://bit.ly/4on0EGm
#ConvergenceScience #CancerResearch
Learn more 👉http://bit.ly/4on0EGm
#ConvergenceScience #CancerResearch
October 21, 2025 at 9:30 AM
Over half of #cancers show MYC deregulation - long seen as “undruggable.” #Research from @imperialcollegeldn.bsky.social & @icr.ac.uk, with #PhD student James Zhang, finds MYC cancers may be vulnerable to NMT inhibitors.
Learn more 👉http://bit.ly/4on0EGm
#ConvergenceScience #CancerResearch
Learn more 👉http://bit.ly/4on0EGm
#ConvergenceScience #CancerResearch
🩺 Are you a #MedStudent doing an iBSc? We're looking for future clinician-scientists to join our intercalated #PhD ( #iPhD) programme in 2026.
Explore projects & apply by 20 Nov 👉 bit.ly/48YA5Tp
Please share with your networks!
#CancerResearch #ConvergenceScience #CRUKFunded
Explore projects & apply by 20 Nov 👉 bit.ly/48YA5Tp
Please share with your networks!
#CancerResearch #ConvergenceScience #CRUKFunded
October 14, 2025 at 9:05 AM
🩺 Are you a #MedStudent doing an iBSc? We're looking for future clinician-scientists to join our intercalated #PhD ( #iPhD) programme in 2026.
Explore projects & apply by 20 Nov 👉 bit.ly/48YA5Tp
Please share with your networks!
#CancerResearch #ConvergenceScience #CRUKFunded
Explore projects & apply by 20 Nov 👉 bit.ly/48YA5Tp
Please share with your networks!
#CancerResearch #ConvergenceScience #CRUKFunded
Congratulations to our 2025 Development Fund awardees! 🎉
From new detection tools to targeted nanotech therapies, these seed funded projects explore bold ideas to improve cancer diagnosis & treatment.
👉 bit.ly/4gV38tf
@icr.ac.uk @imperialcollegeldn.bsky.social @imperialsandc.bsky.social
From new detection tools to targeted nanotech therapies, these seed funded projects explore bold ideas to improve cancer diagnosis & treatment.
👉 bit.ly/4gV38tf
@icr.ac.uk @imperialcollegeldn.bsky.social @imperialsandc.bsky.social
October 6, 2025 at 9:01 AM
Congratulations to our 2025 Development Fund awardees! 🎉
From new detection tools to targeted nanotech therapies, these seed funded projects explore bold ideas to improve cancer diagnosis & treatment.
👉 bit.ly/4gV38tf
@icr.ac.uk @imperialcollegeldn.bsky.social @imperialsandc.bsky.social
From new detection tools to targeted nanotech therapies, these seed funded projects explore bold ideas to improve cancer diagnosis & treatment.
👉 bit.ly/4gV38tf
@icr.ac.uk @imperialcollegeldn.bsky.social @imperialsandc.bsky.social
A study led by our Scientific Director Prof Axel Behrens, found that blocking protein SPP1 can boost survival & stop the spread of #PancreaticCancer in mice. A breakthrough that could pave the way for new targeted treatments.
👉 bit.ly/4gTvG6q
@icr.ac.uk @imperialsandc.bsky.social @nature.com
👉 bit.ly/4gTvG6q
@icr.ac.uk @imperialsandc.bsky.social @nature.com
September 30, 2025 at 1:53 PM
A study led by our Scientific Director Prof Axel Behrens, found that blocking protein SPP1 can boost survival & stop the spread of #PancreaticCancer in mice. A breakthrough that could pave the way for new targeted treatments.
👉 bit.ly/4gTvG6q
@icr.ac.uk @imperialsandc.bsky.social @nature.com
👉 bit.ly/4gTvG6q
@icr.ac.uk @imperialsandc.bsky.social @nature.com
🎤Prof @trevorgraham.bsky.social (@cec-icr.bsky.social)
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
September 26, 2025 at 12:32 PM
🎤Prof @trevorgraham.bsky.social (@cec-icr.bsky.social)
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
🔬 Discoveries in #CancerResearch are stronger when shaped with the people who have experienced #Cancer. Find out why #PPIE matters, how it benefits researchers, and where to get support 👉 bit.ly/41TGN9b
#BetterResearchTogether #ResearchSupport
#BetterResearchTogether #ResearchSupport
September 18, 2025 at 9:15 AM
🔬 Discoveries in #CancerResearch are stronger when shaped with the people who have experienced #Cancer. Find out why #PPIE matters, how it benefits researchers, and where to get support 👉 bit.ly/41TGN9b
#BetterResearchTogether #ResearchSupport
#BetterResearchTogether #ResearchSupport
📢 We're #hiring a Health Economist to lead early-stage health economic modelling and health technology assessment (HTA) for cutting-edge oncology innovations. 💻 💊
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics #Cancer
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics #Cancer
August 26, 2025 at 10:10 AM
📢 We're #hiring a Health Economist to lead early-stage health economic modelling and health technology assessment (HTA) for cutting-edge oncology innovations. 💻 💊
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics #Cancer
Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...
#ConvergenceScience #Economics #Cancer
Talks include:
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
August 21, 2025 at 10:01 AM
Talks include:
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
📣 Promising new drug combination for #OvarianCancer which led to accelerated FDA approval.
Results from the Phase 1 FRAME trial, led by the Drug Development Unit across @icr.ac.uk and @royalmarsden.orga, were recently published in @natmed.nature.com
Find out more 👉 bit.ly/4lW6k9A
Results from the Phase 1 FRAME trial, led by the Drug Development Unit across @icr.ac.uk and @royalmarsden.orga, were recently published in @natmed.nature.com
Find out more 👉 bit.ly/4lW6k9A
July 30, 2025 at 1:01 PM
📣 Promising new drug combination for #OvarianCancer which led to accelerated FDA approval.
Results from the Phase 1 FRAME trial, led by the Drug Development Unit across @icr.ac.uk and @royalmarsden.orga, were recently published in @natmed.nature.com
Find out more 👉 bit.ly/4lW6k9A
Results from the Phase 1 FRAME trial, led by the Drug Development Unit across @icr.ac.uk and @royalmarsden.orga, were recently published in @natmed.nature.com
Find out more 👉 bit.ly/4lW6k9A
🚨 New cross-institutional study from researchers at @imperialcollegeldn.bsky.social, @icr.ac.uk & @cruk-mi.bsky.social use microfluidic “vessel-on-chip” technology to reveal how circulating tumour cells release “shearosomes” and promote metastasis.
👉 bit.ly/3Ib6paq
#Cancer #ConvergenceScience
👉 bit.ly/3Ib6paq
#Cancer #ConvergenceScience
July 4, 2025 at 12:35 PM
🚨 New cross-institutional study from researchers at @imperialcollegeldn.bsky.social, @icr.ac.uk & @cruk-mi.bsky.social use microfluidic “vessel-on-chip” technology to reveal how circulating tumour cells release “shearosomes” and promote metastasis.
👉 bit.ly/3Ib6paq
#Cancer #ConvergenceScience
👉 bit.ly/3Ib6paq
#Cancer #ConvergenceScience
Talks include:
🔎Prof. Franz Schilling (@schillinglab.bsky.social, @tum.de) – Advanced MRI methods to visualize cellular metabolism & function.
🧬Dr Max Douglas (@icr.ac.uk) – Telomere-bound shelterin complex as a molecular switch to inhibit NHEJ.
Chaired by Prof. Kristijan Ramadan (NTU).
🔎Prof. Franz Schilling (@schillinglab.bsky.social, @tum.de) – Advanced MRI methods to visualize cellular metabolism & function.
🧬Dr Max Douglas (@icr.ac.uk) – Telomere-bound shelterin complex as a molecular switch to inhibit NHEJ.
Chaired by Prof. Kristijan Ramadan (NTU).
June 27, 2025 at 11:02 AM
Talks include:
🔎Prof. Franz Schilling (@schillinglab.bsky.social, @tum.de) – Advanced MRI methods to visualize cellular metabolism & function.
🧬Dr Max Douglas (@icr.ac.uk) – Telomere-bound shelterin complex as a molecular switch to inhibit NHEJ.
Chaired by Prof. Kristijan Ramadan (NTU).
🔎Prof. Franz Schilling (@schillinglab.bsky.social, @tum.de) – Advanced MRI methods to visualize cellular metabolism & function.
🧬Dr Max Douglas (@icr.ac.uk) – Telomere-bound shelterin complex as a molecular switch to inhibit NHEJ.
Chaired by Prof. Kristijan Ramadan (NTU).
🧫Our #organoid facility supports @icr.ac.uk & @imperialcollegeldn.bsky.social researchers with training & expert help. Even non-lab scientists, like surgical trainee Caoimhe Walsh, are using it to explore new tools for #cancer diagnosis
🔗 bit.ly/4leguSe
@hannagroupicl.bsky.social
#CancerResearch
🔗 bit.ly/4leguSe
@hannagroupicl.bsky.social
#CancerResearch
June 24, 2025 at 1:13 PM
🧫Our #organoid facility supports @icr.ac.uk & @imperialcollegeldn.bsky.social researchers with training & expert help. Even non-lab scientists, like surgical trainee Caoimhe Walsh, are using it to explore new tools for #cancer diagnosis
🔗 bit.ly/4leguSe
@hannagroupicl.bsky.social
#CancerResearch
🔗 bit.ly/4leguSe
@hannagroupicl.bsky.social
#CancerResearch
🎉 Thank you to everyone involved, we couldn't have done it without our collaborators at @icr.ac.uk, the input from our researchers and our fantastic volunteers who helped make each activity engaging and accessible
Read the full highlights 👉 bit.ly/3I3PtCs
Read the full highlights 👉 bit.ly/3I3PtCs
June 20, 2025 at 8:23 AM
🎉 Thank you to everyone involved, we couldn't have done it without our collaborators at @icr.ac.uk, the input from our researchers and our fantastic volunteers who helped make each activity engaging and accessible
Read the full highlights 👉 bit.ly/3I3PtCs
Read the full highlights 👉 bit.ly/3I3PtCs
📢 We're recruiting an Analytical Scientist in Computational Genomics to develop computational approaches for investigating genomic and transcriptomic determinants in treatment resistant breast cancers 💻 🧬
Find out more and share with your networks 👉 bit.ly/4jYdsAu
Find out more and share with your networks 👉 bit.ly/4jYdsAu
June 19, 2025 at 2:50 PM
📢 We're recruiting an Analytical Scientist in Computational Genomics to develop computational approaches for investigating genomic and transcriptomic determinants in treatment resistant breast cancers 💻 🧬
Find out more and share with your networks 👉 bit.ly/4jYdsAu
Find out more and share with your networks 👉 bit.ly/4jYdsAu
Using the Centre's Microfab Facility a team led by Dr Sam Au at Imperial have launched a company, Avigen, to help accelerate the development of immunotherapies by assessing the binding strength of potential #immunotherapy cells and identifying which ones are more likely to succeed.
👉 bit.ly/4n4tbAA
👉 bit.ly/4n4tbAA
June 17, 2025 at 10:30 AM
Using the Centre's Microfab Facility a team led by Dr Sam Au at Imperial have launched a company, Avigen, to help accelerate the development of immunotherapies by assessing the binding strength of potential #immunotherapy cells and identifying which ones are more likely to succeed.
👉 bit.ly/4n4tbAA
👉 bit.ly/4n4tbAA
We're at the Great Exhibition Road Festival this weekend! Come find us in the Future Medicine zone and try out our activities focussed on how technology can make overall #cancer care better for patients 👇
@icr.ac.uk
@icr.ac.uk
June 7, 2025 at 11:45 AM
We're at the Great Exhibition Road Festival this weekend! Come find us in the Future Medicine zone and try out our activities focussed on how technology can make overall #cancer care better for patients 👇
@icr.ac.uk
@icr.ac.uk
Join us for our next #ConvergingOnCancer seminar where we'll explore these topics with:
➡️Prof @doryenbubeck.bsky.social (@imperialsci.bsky.social)
➡️Dr @claudioalfieri.bsky.social (@icr.ac.uk )
📅 Thursday 5th June, 3-4pm
🖱️ For more information and how to register: bit.ly/3Z80SqS
➡️Prof @doryenbubeck.bsky.social (@imperialsci.bsky.social)
➡️Dr @claudioalfieri.bsky.social (@icr.ac.uk )
📅 Thursday 5th June, 3-4pm
🖱️ For more information and how to register: bit.ly/3Z80SqS
June 2, 2025 at 9:02 AM
Join us for our next #ConvergingOnCancer seminar where we'll explore these topics with:
➡️Prof @doryenbubeck.bsky.social (@imperialsci.bsky.social)
➡️Dr @claudioalfieri.bsky.social (@icr.ac.uk )
📅 Thursday 5th June, 3-4pm
🖱️ For more information and how to register: bit.ly/3Z80SqS
➡️Prof @doryenbubeck.bsky.social (@imperialsci.bsky.social)
➡️Dr @claudioalfieri.bsky.social (@icr.ac.uk )
📅 Thursday 5th June, 3-4pm
🖱️ For more information and how to register: bit.ly/3Z80SqS